ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021
Beyond Chemotherapy and Checkpoint Inhibitors: Weighing the Risks and Benefits of the Novel Therapies for Metastatic Urothelial Carcinoma.
Thomas Powles et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it